Clinical Trials

Gene Variants May Advance Cancer Precision Medicine for Black Men

by Jessica Kent

Newly identified gene variants could possibly lead to precision medicine prostate cancer therapies specifically for black men. Black men in the US are known to disproportionately suffer from prostate...

NIH Funds Centers to Improve Genomic Risk Assessment for Diseases

by Jessica Kent

NIH has announced that it will provide $75 million in funding over five years for the Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network, which aims to...

Machine Learning Method Identifies Adverse Drug Side Effects

by Jessica Kent

An open-source machine learning tool identified proteins associated with adverse drug side effects, providing insight into how the human body responds to drug compounds at the molecular level, a study...

Testing System Leverages Machine Learning to Predict Sepsis Outcomes

by Jessica Kent

Using machine learning algorithms, an extremely sensitive method can analyze biomarkers to predict sepsis outcomes with nearly 100 percent accuracy, according to a study published in Nature...

Big Data Analytics Tool Could Help Guide Cancer Precision Medicine

by Jessica Kent

A big data analytics tool that uses information from multiple cancer types could help researchers identify potential treatments and accelerate precision medicine, a study published in the Journal of...

Consortium to Launch Big Data Biobank for Coronavirus Research

by Jessica Kent

Partners HealthCare, Biogen Inc., and Broad Institute of MIT and Harvard are partnering to launch a big data biobank for coronavirus research. For more coronavirus updates, visit our resource...

Genetic Variant Could Protect People from Alzheimer’s Disease

by Jessica Kent

Researchers at Stanford University have found that a significant fraction of Americans carrying a genetic variant that puts people at high risk for Alzheimer’s disease are protected to some...

Henry Ford Receives $25M Grant to Expand Precision Medicine Program

by Jessica Kent

Henry Ford Health System has received a $25 million grant to accelerate its precision medicine program, with the ultimate goal of creating a Precision Health Center. With the donation, Henry Ford will...

Radiologist, Machine Learning Combo Enhances Breast Cancer Screening

by Jessica Kent

Machine learning tools could help enhance the accuracy of breast cancer screenings when combined with assessments from human radiologists, a study published in JAMA Network Open revealed. Mammography...

New Gene Therapies Institute Aims to Address Regulatory Barriers

by Jessica Kent

The Institute for Gene Therapies (IGT), a new advocacy foundation focused on policy issues surrounding gene therapies, recently launched with the goal of modernizing US regulatory and reimbursement...

FDA Makes Real-World Data Available on Google Cloud Platform

by Jessica Kent

The FDA’s MyStudies platform, a tool that aims to collect real-world data to improve clinical trials and advance medical research, is now available on Google Cloud Platform. Launched in November...

Alzheimer’s Tau Protein Could Advance Cognitive Precision Medicine

by Jessica Kent

Brain imaging of tau-protein “tangles” accurately predicted the location of brain atrophy in patients with Alzheimer’s a year or more in advance, according to a study published in...

Over 70% of Orgs Say Precision Medicine Meets or Tops Expectations

by Jessica Kent

Seventy-three percent of precision medicine adopters say these initiatives have neared or exceeded their expectations, with organizations using clinical analytics solutions and real-world data to meet...

Deep Learning Could Improve Cohort Selection for Clinical Trials

by Jessica Kent

Deep learning models showed promising results in learning key features for clinical trial cohort selection, which could significantly reduce time and costs, according to a study published in JAMIA. In...

Microsoft Using AI to Accelerate Cancer Precision Medicine

by Jessica Kent

Microsoft computer scientists are partnering with researchers at the Jackson Laboratory to develop artificial intelligence technology for cancer treatment, accelerating precision medicine and improving...

How Real-World Data Could Advance Clinical Trials, Precision Medicine

by Jessica Kent

In a society where nearly everything can be done digitally, customization is almost always expected. Whether it’s including special instructions in a takeout order or curating the perfect...

FDA Offers $15M to Fund Clinical Trials for Rare Diseases

by Jessica Kent

The FDA announced that it has awarded 12 new clinical trial research grants totaling $15 million over the next four years to help accelerate the development of medical products for patients with rare...

UW-Madison Center Will Coordinate Cancer Clinical Trial Data

by Jessica Kent

A research team from the University of Wisconsin-Madison will lead the nation’s coordinating center for the National Cancer Institute (NCI) Cancer Prevention Clinical Trials Network...

NIH Research Centers Will Advance Precision Medicine for Alzheimer’s

by Jessica Kent

The National Institutes on Aging (NIA), part of NIH, have launched two new research centers designed to advance precision medicine for Alzheimer’s disease and reinvigorate the drug development...

AHA: Precision Medicine Could Improve Heart Failure Treatment

by Jessica Kent

Precision medicine could someday improve heart failure care by identifying high-risk patients and personalizing heart failure therapies, according to a scientific statement from the American Heart...